Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P1TY
|
|||
Former ID |
DNC005085
|
|||
Drug Name |
3-(tetradecylamino)propylphosphonic acid
|
|||
Synonyms |
3-(tetradecylamino)propylphosphonic acid; CHEMBL334213; 725724-60-7; CTK2H2323; DTXSID50658353; BDBM50148403; (3-Tetradecylamino-propyl)-phosphonic acid; [3-(Tetradecylamino)propyl]phosphonic acid; Phosphonic acid, [3-(tetradecylamino)propyl]-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H38NO3P
|
|||
Canonical SMILES |
CCCCCCCCCCCCCCNCCCP(=O)(O)O
|
|||
InChI |
1S/C17H38NO3P/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-16-14-17-22(19,20)21/h18H,2-17H2,1H3,(H2,19,20,21)
|
|||
InChIKey |
ROTPOJPBVJTWLI-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 725724-60-7
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sphingosine-1-phosphate receptor 1 (S1PR1) | Target Info | Inhibitor | [1] |
KEGG Pathway | FoxO signaling pathway | |||
Sphingolipid signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway | ||||
IL2 Signaling Pathway | ||||
Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | |||
S1P3 pathway | ||||
S1P1 pathway | ||||
Sphingosine 1-phosphate (S1P) pathway | ||||
PDGFR-beta signaling pathway | ||||
Reactome | G alpha (i) signalling events | |||
Lysosphingolipid and LPA receptors | ||||
WikiPathways | Signal Transduction of S1P Receptor | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 re... J Med Chem. 2004 Dec 30;47(27):6662-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.